Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $74.3900 (-4.16%) ($73.9800 - $77.6900) on Wed. Apr. 17, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.05% (three month average) | RSI | 30 | Latest Price | $74.3900(-4.16%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX declines -1.5% a day on average for past five trading days. | Weekly Trend | BAX declines -1.9% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(56%) SPLV(52%) XLP(51%) VYM(50%) IVE(48%) | Factors Impacting BAX price | BAX will decline at least -0.525% in a week (0% probabilities). TLT(-19%) IFRA(-10%) VXX(-8%) VIXM(-8%) UUP(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.525% (StdDev 1.05%) | Hourly BBV | 0 () | Intraday Trend | -4.2% | | | |
|
Resistance Level | $79.4 | 5 Day Moving Average | $78.15(-4.81%) | 10 Day Moving Average | $79.1(-5.95%) | 20 Day Moving Average | $79.4(-6.31%) | To recent high | -9% | To recent low | 7.6% | Market Cap | $37.952b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |